logo
Select company
Select metric
$ 641KFree Cash Flow
VS
Market
43
Sector
75
Industry
48
History
73
$ 27.32Close
$ 20.47 - $ 28.75 52-Week Range
Ticker Information

Ticker

BLFS

Company Name

BIOLIFE SOLUTIONS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

BIOLIFE SOLUTIONS INC - Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BLFS - FCF Historical data
DateCapital ExpenditureFree Cash FlowNet Cash Flow - Operations
6/30/2025$ 14.9M$ 641K$ 15.54M
3/31/2025$ 4.9M$ 9.73M$ 14.63M
12/31/2024$ 5.29M$ 3.14M$ 8.43M
9/30/2024$ 6.88M$ 2.22M$ 9.1M
6/30/2024$ 7.73M$ -7.81M$ -84K
3/31/2024$ 7.76M$ -22.02M$ -14.26M
12/31/2023$ 11.24M$ -23.73M$ -12.5M
9/30/2023$ 14.57M$ -21.52M$ -6.95M
6/30/2023$ 16.11M$ -17.19M$ -1.08M
3/31/2023$ 15.95M$ -19.22M$ -3.28M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOLIFE SOLUTIONS INC's latest trailing twelve months (TTM) FCF stands at $ -294K.
  • Over the past 5 years, BIOLIFE SOLUTIONS INC's average FCF has been $ -13.11M.
  • The median FCF for BIOLIFE SOLUTIONS INC during this period was $ -19.07M
  • BIOLIFE SOLUTIONS INC reached its highest FCF over the past 5 years at $ 9.73M.
  • The lowest FCF recorded by BIOLIFE SOLUTIONS INC in the same timeframe $ -27.87M

BIOLIFE SOLUTIONS INC's FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Benchmarks
CompanyFCF
SNDX : SYNDAX PHARMACEUTICALS INC $ -302.67MIRMD : IRADIMED CORP $ 13.33MNRIX : NURIX THERAPEUTICS INC $ -241.36MURGN : UROGEN PHARMA LTD $ -123.53MTBPH : THERAVANCE BIOPHARMA INC $ 244.78MPDEX : PRO DEX INC $ -2.93MSMTI : SANARA MEDTECH INC $ 142.37KPLSE : PULSE BIOSCIENCES INC $ -44.73MCBLL : CERIBELL INC $ -38.6MZVRA : ZEVRA THERAPEUTICS INC $ -46.53M

Definition of Free Cash Flow

[Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
CF - Operations - CapEx
(=) FCF
FCF for BIOLIFE SOLUTIONS INC is calculated as follows: CF - Operations [ $ 3.38M ] - CapEx [ $ 3.68M ]
(=) FCF [ $ -294K ]

BLFS - Free Cash Flow, Last 5 years

$ -27.87M

Minimum

Sep 30, 2022

$ 9.73M

Maximum

Mar 31, 2025

$ -13.11M

Average

$ -19.07M

Median

FCF Benchmark Analysis

The chart above depicts the distribution of FCF for companies in the Total Stock Market. The average FCF of the companies is $ 28.75M with a standard deviation of $ 117.92M.
The following table provides additional summary stats:
FCF in the Market:
filtered constituents3.3K
min$ -356.66M
max$ 390M
average$ 28.75M
median$ 461K
std$ 117.92M